Factors Affecting Community Pharmacist’s Knowledge About Chronic Obstructive Pulmonary Disease (COPD) Management in China: A Cross-Sectional Survey Study

References

• World Health Organization. Chronic respiratory diseases: overview. Available from: https://www.who.int/health-topics/chronic-respiratory-diseases#tab=tab_1. Accessed 417, 2020.
   Google Scholar
• World Health Organization. Chronic respiratory diseases: burden of COPD; Available from: https://www.who.int/respiratory/copd/burden/. Accessed 417, 2020.
   Google Scholar
• López‐CamposJL, TanW, SorianoJB. Global burden of COPD. Respi. 2016;21(1):14–23. doi:10.1111/resp.12660
   PubMed Web of Science ®Google Scholar
• BerryCE, WiseRA. Mortality in COPD: causes, risk factors, and prevention. J COPD. 2010;7(5):375–382. doi:10.3109/15412555.2010.510160
   PubMedGoogle Scholar
• SorianoJB, ZielinskiJ, PriceD. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374(9691):721–732. doi:10.1016/S0140-6736(09)61290-319716965
   PubMed Web of Science ®Google Scholar
• BarnesP, CelliB. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185. doi:10.1183/09031936.0012800819407051
   PubMed Web of Science ®Google Scholar
• Ehteshami-AfsharS, FitzGeraldJ, Doyle-WatersM, et al. The global economic burden of asthma and chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2016;20(1):11–23. doi:10.5588/ijtld.15.047226688525
   PubMed Web of Science ®Google Scholar
• ManninoDM, ThornD, SwensenA, et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–969. doi:10.1183/09031936.0001240818579551
   PubMed Web of Science ®Google Scholar
• MohanA, ChandraS, AgarwalD, et al. Prevalence of viral infection detected by PCR and RT‐PCR in patients with acute exacerbation of COPD: a systematic review. Respirology. 2010;15(3):536–542. doi:10.1111/j.1440-1843.2010.01722.x20415983
   PubMed Web of Science ®Google Scholar
• KoFW, HuiDS. Air pollution and chronic obstructive pulmonary disease. Respirology. 2012;17(3):395–401. doi:10.1111/j.1440-1843.2011.02112.x22142380
   PubMed Web of Science ®Google Scholar
• HuangF, ZhaoA, ChenRJ, et al. Ambient temperature and outpatient visits for acute exacerbation of chronic bronchitis in Shanghai: a time series analysis. Biomed Environ Sci. 2015;28(1):76–79.25566865
   PubMed Web of Science ®Google Scholar
• GardinerC, GottM, PayneS, et al. Exploring the care needs of patients with advanced COPD: an overview of the literature. Respir Med. 2010;104(2):159–165. doi:10.1016/j.rmed.2009.09.00719818590
   PubMed Web of Science ®Google Scholar
• van der MolenT, van BovenJF, MaguireT, et al. Optimizing identification and management of COPD patients–reviewing the role of the community pharmacist. Br J Clin Pharm. 2017;83(1):192–201. doi:10.1111/bcp.13087
   PubMed Web of Science ®Google Scholar
• FathimaM, Naik-PanvelkarP, SainiB, et al. The role of community pharmacists in screening and subsequent management of chronic respiratory diseases: a systematic review. J Oncol Pharm Pract. 2013;11(4):228.
   Google Scholar
• VermaA, HarrisonA, TorunP, et al. Are pharmacists reducing COPD’S impact through smoking cessation and assessing inhaled steroid use? Respir Med. 2012;106(2):230–234. doi:10.1016/j.rmed.2011.08.01121899999
   PubMed Web of Science ®Google Scholar
• ZhongH, NiX-J, CuiM, et al. Evaluation of pharmacist care for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Clin Pharm. 2014;36(6):1230–1240. doi:10.1007/s11096-014-0024-925330865
   PubMed Web of Science ®Google Scholar
• WrightD, TwiggM, ThornleyT. Chronic obstructive pulmonary disease case finding by community pharmacists: a potential cost‐effective public health intervention. Int J Pharm Pract. 2015;23(1):83–85. doi:10.1111/ijpp.1216125371146
   PubMedGoogle Scholar
• CastilloD, BurgosF, GuaytaR, et al. Airflow obstruction case finding in community-pharmacies: a novel strategy to reduce COPD underdiagnosis. Respir Med. 2015;109(4):475–482. doi:10.1016/j.rmed.2015.02.00925754101
   PubMed Web of Science ®Google Scholar
• JarabAS, AlQudahSG, KhdourM, et al. Impact of pharmaceutical care on health outcomes in patients with COPD. Int J Clin Pharm. 2012;34(1):53–62. doi:10.1007/s11096-011-9585-z22101426
   PubMed Web of Science ®Google Scholar
• WrightD, TwiggM, BartonG, et al. An evaluation of a multi‐site community pharmacy–based chronic obstructive pulmonary disease support service. Int J Pharm Pract. 2015;23(1):36–43. doi:10.1111/ijpp.1216525409898
   PubMedGoogle Scholar
• TommeleinE, MehuysE, Van HeesT, et al. Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial. Br J Clin Pharmacol. 2014;77(5):756–766. doi:10.1111/bcp.1224224117908
   PubMed Web of Science ®Google Scholar
• International Pharmaceutical Federation (FIP). Beating non-communicable diseases in the community; 2019 Available from: https://www.fip.org/files/content/publications/2019/beating-ncds-in-the-community-the-contribution-of-pharmacists.pdf. Accessed 417, 2020.
   Google Scholar
• TommeleinE, TollenaereK, MehuysE, et al. Pharmaceutical care for patients with COPD in Belgium and views on protocol implementation. Int J Clin Pharm. 2014;36(4):697–701. doi:10.1007/s11096-014-9956-324858598
   PubMed Web of Science ®Google Scholar
• HeikkilaJM, ParkkamakiS, SalimakiJ, et al. Community pharmacists’ knowledge of COPD, and practices and perceptions of medication counseling of COPD patients. Int J COPD. 2018;13:2065–2074. doi:10.2147/copd.S159726
   Google Scholar
• Certification Center for Licensed Pharmacist of NMPA. Statistics of licensed pharmacist registration; 2019 Available from: http://www.cqlp.org/info/link.aspx?id=3681&page=1. Accessed 417, 2020.
   Google Scholar
• International Pharmaceutical Federation (FIP). Pharmacy workforce intelligence: global trends report; 2018 Available from: https://www.fip.org/www/streamfile.php?filename=fip/PharmacyEducation/Workforce_Report_2018.pdf. Accessed 1123, 2020.
   Google Scholar
• HuM, YeeG, ZhouN, et al. Development and current status of clinical pharmacy education in China. Am J Pharm Educ. 2014;78(8):157. doi:10.5688/ajpe78815725386022
   PubMed Web of Science ®Google Scholar
• Certification Center for Lisenced pharmacist of NMPA. Who can apply for the national qualification examination for licensed pharmacists; Available from: http://www.cqlp.org/info/link.aspx?id=3714&page=1. Accessed 417, 2020.
   Google Scholar
• JiangJ, LiuY, WangY, et al. Clinical pharmacy education in China. Am J Pharm Educ. 2011;75(3):2. doi:10.5688/ajpe75357c21451754
   PubMed Web of Science ®Google Scholar
• LiangJ, AbramsonMJ, GeorgeJ. Educational interventions for health professionals managing COPD in primary care. Cochrane Database Syst Rev. 2017;2017(5).
   Google Scholar
• BloomBS. Effects of continuing medical education on improving physician clinical care and patient health: a review of systematic reviews. Int J Technol Assess Health Care. 2005;21(3):380–385. doi:10.1017/S026646230505049X16110718
   PubMed Web of Science ®Google Scholar
• RobertsonMK, UmbleKE, CerveroRM. Impact studies in continuing education for health professions: update. J Contin Educ Health Prof. 2003;23(3):146–156. doi:10.1002/chp.134023030514528785
   PubMedGoogle Scholar
• Global Initiative for Chronic Obstructive Pulmonary Disease. 2020 GOLD reports; 2019 Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf. Accessed 417, 2020.
   Google Scholar
• CawleyMJ, WarningWJ. Impact of a pharmacist-driven spirometry clinic service within a community family health center: a 5-year retrospective review. J Res Pharm Pract. 2018;7(2):88. doi:10.4103/jrpp.JRPP_17_10130050962
   PubMed Web of Science ®Google Scholar
• CawleyMJ, WarningWJ. Pharmacists performing quality spirometry testing: an evidence based review. Int J Pharm Pract. 2015;37(5):726–733.
   Google Scholar
• Ministry Of Commerce People’s Republic Of China. Statistical analysis report on the operation of the pharmaceutical distribution industry; 2017 Available from: http://yplt.mofcom.gov.cn/stat/page/auth/DrugWall.html. Accessed 417, 2020.
   Google Scholar
• Xinhua News Agency. Healthy China 2030 planning outline; 2016 Available from: http://www.gov.cn/xinwen/2016-10/25/content_5124174.htm. Accessed 417, 2020.
   Google Scholar
• National Healthcare Security Administration. Drug catalog of national basic healthcare, industrial injury insurance and maternity insurance; 2019 Available from: http://www.nhsa.gov.cn/art/2019/8/20/art_37_1666.html. Accessed 417, 2020.
   Google Scholar
• Certification Center for Lisenced pharmacist of NMPA. Business specifications of licensed pharmacist; 2016 Available from: http://www.cqlp.org/cqlpadminmanage/upfiles/201612/20161205164252986.pdf. Accessed 417, 2020.
   Google Scholar